PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26079827-6 2015 Cells with decreased cN-II expression were resistant to the nucleoside analog fludarabine confirming the involvement of cN-II in the metabolism of this drug. fludarabine 78-89 5'-nucleotidase, cytosolic II Homo sapiens 21-26 25857773-2 2015 Recently, a number of papers demonstrated the involvement of cN-II in the mechanisms of resistance to antitumor drugs such as cytarabine, gemcitabine and fludarabine. fludarabine 154-165 5'-nucleotidase, cytosolic II Homo sapiens 61-66 25857773-12 2015 SENTENCE: Resistance to fludarabine, gemcitabine and cytarabine can be determined by an increase of cN-II both through dephosphorylation of active drugs and perturbation of nucleotide pool. fludarabine 24-35 5'-nucleotidase, cytosolic II Homo sapiens 100-105 25656700-0 2015 The purine analog fludarabine acts as a cytosolic 5"-nucleotidase II inhibitor. fludarabine 18-29 5'-nucleotidase, cytosolic II Homo sapiens 40-68 25656700-3 2015 In this paper we present evidence showing that, among the commonly used cytotoxic nucleoside analogs, fludarabine can act as a cN-II inhibitor. fludarabine 102-113 5'-nucleotidase, cytosolic II Homo sapiens 127-132 25656700-4 2015 In vitro studies using the wild type recombinant cN-II demonstrated that fludarabine inhibited enzymatic activity in a mixed manner (Ki 0.5 mM and Ki" 9 mM), whereas no inhibition was observed with clofarabine and cladribine. fludarabine 73-84 5'-nucleotidase, cytosolic II Homo sapiens 49-54 25656700-7 2015 This is in line with the hypothesis that fludarabine acts as a cN-II inhibitor and supports the idea of using cN-II inhibitors in association with other drugs to increase their therapeutic effect and decrease their resistance. fludarabine 41-52 5'-nucleotidase, cytosolic II Homo sapiens 63-68 25656700-7 2015 This is in line with the hypothesis that fludarabine acts as a cN-II inhibitor and supports the idea of using cN-II inhibitors in association with other drugs to increase their therapeutic effect and decrease their resistance. fludarabine 41-52 5'-nucleotidase, cytosolic II Homo sapiens 110-115 16629121-3 2006 We have investigated the dephosphorylation of monophosphorylated fludarabine (F-ara-AMP) by the purified cytoplasmic 5"-nucleotidase cN-II using HPLC and NMR. fludarabine 65-76 5'-nucleotidase, cytosolic II Homo sapiens 133-138 16629121-4 2006 These studies clearly showed that cN-II was able to convert F-ara-AMP into its non phosphorylated form, F-ara-A, with a Km in the millimolar range and Vmax = 35 nmol/min/mg, with both methods. fludarabine 60-67 5'-nucleotidase, cytosolic II Homo sapiens 34-39